comparemela.com

Latest Breaking News On - Algernon pharmaceuticals inc - Page 9 : comparemela.com

Algernon Pharmaceuticals Inc receives Notice of Allowance from US Patent and Trademark Office for Repirinast

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO).

Biotech Co Set To Reach New Highs

Algernon Pharmaceuticals Inc announces successful dosing of second cohort in Phase 1 DMT clinical study

Algernon Pharmaceuticals Inc announces successful dosing of second cohort in Phase 1 DMT clinical study
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Algernon Pharmaceuticals Inc says wholly-owned subsidiary s Reg A+ offering gets US SEC qualification

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said its wholly-owned subsidiary, Algernon NeuroScience (AGN Neuro), has qualified its Form 1-A.

Algernon Pharmaceuticals (OTCMKTS:AGNPF) Shares Down 14 8%

Shares of Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Rating) dropped 14.8% on Tuesday . The stock traded as low as $0.22 and last traded at $0.23. Approximately 23,408 shares were traded during mid-day trading, an increase of 93% from the average daily volume of 12,135 shares. The stock had previously closed at $0.27. Algernon Pharmaceuticals […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.